Literature DB >> 1618946

Attenuated development of ischemic brain edema in vasopressin-deficient rats.

L D Dickinson1, A L Betz.   

Abstract

Brain edema formation was investigated in the vasopressin-deficient Brattleboro rat using a middle cerebral artery occlusion model of early ischemic injury. Water and sodium accumulation after 4 h of ischemia were attenuated 36 and 20%, respectively, in the Brattleboro strain as compared to the control Long-Evans strain. This effect was independent of differences in animal size and state of hydration. In addition, measurements of cerebral blood flow indicated that Brattleboro and Long-Evans rats had equal levels of ischemia following middle cerebral artery occlusion. Systemic treatment of Brattleboro rats with vasopressin normalized their serum electrolyte concentrations and osmolarity but did not alter sodium or water accumulation in the ischemic brain. In contrast, intraventricular administration of vasopressin in Brattleboro rats increased edema formation to that seen in control rats. The reduced water and sodium accumulation in Brattleboro rats subjected to middle cerebral artery occlusion may be related to alterations in blood-brain barrier permeability since the blood-to-brain sodium flux was 36% less in the ischemic tissue of the Brattleboro as compared to the Long-Evans strain. These results support the hypothesis that central vasopressin is a regulator of brain volume and electrolyte homeostasis. Furthermore, our findings suggest a role for central vasopressin in the development of ischemic brain edema.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618946     DOI: 10.1038/jcbfm.1992.93

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  13 in total

1.  Vasopressin amplifies the production of proinflammatory mediators in traumatic brain injury.

Authors:  Joanna Szmydynger-Chodobska; Leora M Fox; Kirsten M Lynch; Brian J Zink; Adam Chodobski
Journal:  J Neurotrauma       Date:  2010-08       Impact factor: 5.269

2.  Real-time monitoring of changes in brain extracellular sodium and potassium concentrations and intracranial pressure after selective vasopressin-1a receptor inhibition following focal traumatic brain injury in rats.

Authors:  Aristotelis S Filippidis; Xiuyin Liang; Weili Wang; Shanaaz Parveen; Clive M Baumgarten; Christina R Marmarou
Journal:  J Neurotrauma       Date:  2014-05-28       Impact factor: 5.269

3.  Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice.

Authors:  Sandro M Krieg; Sebastian Sonanini; Nikolaus Plesnila; Raimund Trabold
Journal:  J Neurotrauma       Date:  2014-12-16       Impact factor: 5.269

4.  Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury.

Authors:  Anatol Manaenko; Nancy Fathali; Nikan H Khatibi; Tim Lekic; Yu Hasegawa; Robert Martin; Jiping Tang; John H Zhang
Journal:  Neurochem Int       Date:  2011-01-20       Impact factor: 3.921

Review 5.  The Emerging Role of Copeptin.

Authors:  R Jalleh; D J Torpy
Journal:  Clin Biochem Rev       Date:  2021-02

6.  Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.

Authors:  Christina R Marmarou; Xiuyin Liang; Naqeeb H Abidi; Shanaz Parveen; Keisuke Taya; Scott C Henderson; Harold F Young; Aristotelis S Filippidis; Clive M Baumgarten
Journal:  Brain Res       Date:  2014-06-13       Impact factor: 3.252

7.  Cerebral microvascular endothelial cell Na/H exchange: evidence for the presence of NHE1 and NHE2 isoforms and regulation by arginine vasopressin.

Authors:  Tina I Lam; Phyllis M Wise; Martha E O'Donnell
Journal:  Am J Physiol Cell Physiol       Date:  2009-05-20       Impact factor: 4.249

8.  Hypoxic and ischemic hypoxia exacerbate brain injury associated with metabolic encephalopathy in laboratory animals.

Authors:  Z S Vexler; J C Ayus; T P Roberts; C L Fraser; J Kucharczyk; A I Arieff
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

Review 9.  Mitochondria, Oxytocin, and Vasopressin: Unfolding the Inflammatory Protein Response.

Authors:  Evan A Bordt; Caroline J Smith; Tyler G Demarest; Staci D Bilbo; Marcy A Kingsbury
Journal:  Neurotox Res       Date:  2018-09-27       Impact factor: 3.911

10.  Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke.

Authors:  Xiaoqin Liu; Shin Nakayama; Mahmood Amiry-Moghaddam; Ole Petter Ottersen; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.